Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Curia, formerly AMRI, announced that they will collaborate on a robust development platform for Replicate’s srRNA therapeutics. The strategic collaboration unites two RNA therapeutics industry leaders.
read more
Wednesday, December 02, 2020
Bora Pharmaceuticals announced the CDMO has successfully completed the acquisition of GSK’s Mississauga, Ontario facility.
read more
Vectura and Inspira Pharmaceuticals have announced an agreement to develop an inhaled formulation of Inspira’s lead drug candidate for the potential treatment of COVID-19.
read more
Zenith Technologies is expanding its US presence by opening two new offices on the West Coast of the US to meet greater demand for its automation, process control and serialization technology support services.
read more
Wednesday, February 12, 2025
Axplora announced a €50 million client investment at its Mourenx site in Southwest France, securing its position as a key player in the fight against cardiovascular and metabolic diseases.
read more
Avara has agreed to acquire the largest sterile manufacturing facility for injectable medicines in Canada from a global pharmaceutical company, as part of a continuing expansion of its global footprint.
read more
Wednesday, January 04, 2023
MA–Nova Biomedical is pleased to announce the launch of BioProfile FAST CDVTM, a high-throughput, fully automated viable cell density and viability analyzer capable of producing results in under 70 seconds with just 100uL of sample volume. In ...
read more
Novartis has announced that the Phase III study of Afinitor® (everolimus) tablets plus best supportive care in patients with advanced nonfunctional neuroendocrine tumors (NET) of gastrointestinal (GI) or lung origin met its primary endpoint.
read more
Tuesday, February 17, 2026
Uniphar announced a strategic merger between Uniphar | Clinical and BMclinical, reinforcing Uniphar | Clinical’s integrated clinical supply offering and solidifying its position as a trusted partner to pharmaceutical and biotech companies worldwide.
read more
Alcami announced a $10 million investment to expand its laboratory operation in Durham, North Carolina. The investment adds over 6700 ft² to the existing laboratory footprint, new equipment, and capabilities to enhance drug substance and drug product...
read more
Asimov announced the expansion of its LV Edge System with the launch of a fully stable cell line development service.
read more
Monday, September 25, 2017
ADC Biotechnology announces it has secured investment for the construction of an $11 million bioconjugation facility at its new site in Deeside, North Wales, UK.
read more
Thursday, September 26, 2019
Torrent is expanding its recall for Losartan Potassium Tablets USP and Losartan Potassium/hydrochlorothiazide tablets to the consumer level.
read more
Wednesday, April 22, 2020
Keystone Folding Box has incorporated new die cutting and gluing equipment into its production facility.
read more
DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM announced today that their new cGMP custom biopharmaceutical manufacturing 'biologics plant of the future' will open in June 2013.
read more